journal article·2021-10-13Open access

Lymph-Node-Targeted Cholesterolized TLR7 Agonist Liposomes Provoke a Safe and Durable Antitumor Response

Dandan Wan, Haiying Que, Li Chen, Tianxia Lan, Weiqi Hong, Cai He, Jingyun Yang, Yuquan Wei, Xiawei Wei

Nano Letters· Volume 21· Issue 19

Abstract

T cell responses. Furthermore, 1V209-Cho-Lip induced tumor-specific memory immunity to inhibit cancer recurrence and metastasis. These results indicate that cholesterol conjugation with 1V209 is an effective approach to target lymph nodes and to reduce the adverse effects. This work provides a rational basis for the distribution optimization of TLR agonists for potential clinical use.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Immune Response and Inflammation · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Aging Research and Cancer Drug Target, State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu, Sichuan 610041, PR China

Funding

the National Natural Science Foundation Regional Innovation and Development · the Development Program of China · the Excellent Youth Foundation of Sichuan Scientific Committee Grant in China

References (40)

Show source-provided references
1. 10.1016/j.biopha.2020.10982110.1016/j.biopha.2020.109821 ↗
2. 10.1038/ni.239210.1038/ni.2392 ↗
3. 10.1002/jcp.2778210.1002/jcp.27782 ↗
4. 10.1016/j.it.2017.04.00210.1016/j.it.2017.04.002 ↗
5. 10.1146/annurev.immunol.22.012703.10453810.1146/annurev.immunol.22.012703.104538 ↗
6. 10.1016/j.biomaterials.2020.12020810.1016/j.biomaterials.2020.120208 ↗
7. 10.1038/nrc325810.1038/nrc3258 ↗
8. 10.1126/science.123222710.1126/science.1232227 ↗
9. 10.1093/annonc/mdx68310.1093/annonc/mdx683 ↗
10. 10.4049/jimmunol.160114510.4049/jimmunol.1601145 ↗
11. 10.1080/2162402X.2018.152625010.1080/2162402X.2018.1526250 ↗
12. 10.1172/JCI7991510.1172/JCI79915 ↗
13. 10.1586/ecp.11.510.1586/ecp.11.5 ↗
14. 10.1177/009127000730376610.1177/0091270007303766 ↗
15. 10.1182/blood-2008-04-15171210.1182/blood-2008-04-151712 ↗
16. 10.1182/blood-2012-05-43239310.1182/blood-2012-05-432393 ↗
17. 10.1073/pnas.063169610010.1073/pnas.0631696100 ↗
18. 10.1074/jbc.M31161820010.1074/jbc.M311618200 ↗
19. 10.1038/sj.onc.121091310.1038/sj.onc.1210913 ↗
20. 10.1073/pnas.160081611310.1073/pnas.1600816113 ↗
21. 10.1073/pnas.110520010810.1073/pnas.1105200108 ↗
22. 10.1038/nature1297810.1038/nature12978 ↗
23. 10.1038/nbt133210.1038/nbt1332 ↗
24. 10.1073/pnas.110426410810.1073/pnas.1104264108 ↗
25. 10.1038/nmat296010.1038/nmat2960 ↗
26. 10.1007/s11427-018-9470-910.1007/s11427-018-9470-9 ↗
27. 10.3389/fimmu.2019.0086310.3389/fimmu.2019.00863 ↗
28. 10.1126/science.aal362210.1126/science.aal3622 ↗
29. 10.1126/science.aal366210.1126/science.aal3662 ↗
30. 10.4161/cc.5.8.264610.4161/cc.5.8.2646 ↗
31. 10.1126/science.107142010.1126/science.1071420 ↗
32. 10.1038/nbt133910.1038/nbt1339 ↗
33. 10.1016/j.cmet.2013.04.00210.1016/j.cmet.2013.04.002 ↗
34. 10.1021/ja046663o10.1021/ja046663o ↗
35. 10.1002/anie.20150878310.1002/anie.201508783 ↗
36. 10.1002/anie.20110126610.1002/anie.201101266 ↗
37. 10.1038/ni75810.1038/ni758 ↗
38. 10.1002/adfm.20170724910.1002/adfm.201707249 ↗
39. 10.1358/dot.1999.35.7.54826310.1358/dot.1999.35.7.548263 ↗
40. 10.3967/bes2014.01210.3967/bes2014.012 ↗